|
CWF19L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.578400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.041500E-03 |
| Normal-vs-Stage2 |
1.526950E-01 |
| Normal-vs-Stage3 |
9.179800E-02 |
| Normal-vs-Stage4 |
5.574100E-02 |
| Stage1-vs-Stage2 |
4.869000E-01 |
| Stage1-vs-Stage3 |
6.215200E-01 |
| Stage1-vs-Stage4 |
9.462200E-01 |
| Stage2-vs-Stage3 |
8.467800E-01 |
| Stage2-vs-Stage4 |
6.092200E-01 |
| Stage3-vs-Stage4 |
7.404000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.498500E-02 |
| Normal-vs-AfricanAmerican |
3.197200E-03 |
| Normal-vs-Asian |
4.219000E-01 |
| Caucasian-vs-AfricanAmerican |
7.770000E-02 |
| Caucasian-vs-Asian |
6.054600E-01 |
| AfricanAmerican-vs-Asian |
9.307200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.619600E-03 |
| Normal-vs-Female |
2.804200E-01 |
| Male-vs-Female |
3.514300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.400800E-03 |
| Normal-vs-Extreme_Weight |
9.819000E-03 |
| Normal-vs-Obese |
1.497780E-01 |
| Normal-vs-Extreme_Obese |
6.599100E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.824200E-01 |
| Normal_Weight-vs-Obese |
1.285760E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.668200E-01 |
| Extreme_Weight-vs-Obese |
1.441390E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.604600E-01 |
| Obese-vs-Extreme_Obese |
8.890400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.610200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.856300E-02 |
| Normal-vs-Age(61-80Yrs) |
1.378180E-02 |
| Normal-vs-Age(81-100Yrs) |
3.317100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.056200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.402300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.582100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.726800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.004300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.549700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.525600E-02 |
| Normal-VS-Type2 PRCC |
4.631400E-04 |
| Normal-VS-KIRP CIMP |
5.008400E-01 |
| Normal-VS-Unclassified PRCC |
4.827800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.082800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.813200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.823200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.966300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.352010E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.784600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.096360E-02 |
| Normal-vs-N1 |
7.812800E-01 |
| Normal-vs-N2 |
1.226000E-01 |
| N0-vs-N1 |
9.659900E-02 |
| N0-vs-N2 |
7.730000E-01 |
| N1-vs-N2 |
3.837400E-01 |
|
|
